JP2007523111A5 - - Google Patents

Download PDF

Info

Publication number
JP2007523111A5
JP2007523111A5 JP2006553508A JP2006553508A JP2007523111A5 JP 2007523111 A5 JP2007523111 A5 JP 2007523111A5 JP 2006553508 A JP2006553508 A JP 2006553508A JP 2006553508 A JP2006553508 A JP 2006553508A JP 2007523111 A5 JP2007523111 A5 JP 2007523111A5
Authority
JP
Japan
Prior art keywords
factor xiii
preparation
preparation according
manufacture
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006553508A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007523111A (ja
Filing date
Publication date
Priority claimed from EP04003950A external-priority patent/EP1566183A1/en
Application filed filed Critical
Publication of JP2007523111A publication Critical patent/JP2007523111A/ja
Publication of JP2007523111A5 publication Critical patent/JP2007523111A5/ja
Pending legal-status Critical Current

Links

JP2006553508A 2004-02-20 2005-02-15 虚血性組織の潅流を刺激するためのxiii因子の使用 Pending JP2007523111A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04003950A EP1566183A1 (en) 2004-02-20 2004-02-20 Use of factor XIII for stimulating the perfusion of ischemic tissue
PCT/EP2005/001495 WO2005079839A1 (en) 2004-02-20 2005-02-15 Use of factor xiii for stimulating the perfusion of ischemic tissue

Publications (2)

Publication Number Publication Date
JP2007523111A JP2007523111A (ja) 2007-08-16
JP2007523111A5 true JP2007523111A5 (https=) 2008-04-03

Family

ID=34707356

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006553508A Pending JP2007523111A (ja) 2004-02-20 2005-02-15 虚血性組織の潅流を刺激するためのxiii因子の使用

Country Status (11)

Country Link
US (1) US20070167361A1 (https=)
EP (2) EP1566183A1 (https=)
JP (1) JP2007523111A (https=)
KR (1) KR20060123567A (https=)
AT (1) ATE429244T1 (https=)
AU (1) AU2005215114B2 (https=)
CA (1) CA2556805C (https=)
DE (1) DE602005014085D1 (https=)
DK (1) DK1718328T3 (https=)
ES (1) ES2325996T3 (https=)
WO (1) WO2005079839A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITTO20130532A1 (it) * 2013-06-27 2014-12-28 Donato Gemmati Nuovo biomarcatore prognostico nell'infarto acuto del miocardio

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU674061B2 (en) * 1993-03-30 1996-12-05 Hoechst Japan Limited Factor XIII for treatment of skin wounds
WO1998051333A1 (en) * 1997-05-14 1998-11-19 Zymogenetics, Inc. Use of factor xiii for the manufacture of a medicament for the treatment of reperfusion injury and mucosal damage
WO2003065997A2 (en) * 2002-02-06 2003-08-14 Vicor Technologies, Inc. Anti-infarction molecules

Similar Documents

Publication Publication Date Title
JP2010530001A5 (https=)
RU2533217C3 (ru) Препарат, содержащий инсулин, никотинамид и аминокислоту
JP2012505014A5 (https=)
NO20074824L (no) Forlengelse av tid til sykdomsprogresjon eller overlevelse hos kreftpasienter
HRP20131120T1 (hr) Farmaceutski pripravak koji sadrži (1s)-1,5-anhidro-1-[5-(4-etoksibenzil)-2-metoksi-4-metilfenil]-1-tio-d-glucitol i metformin, te njegova uporaba za lijeäśenje dijabetesa
RU2015144182A (ru) Пиразоламидное соединение и его применения в медицине
JP2009137951A5 (https=)
JP2008545703A5 (https=)
EA201070084A1 (ru) Новое применение известных фармакологически активных химических соединений
JP2007523111A5 (https=)
CL2013000021A1 (es) Forma cristalina delta de la sal de arginina de perindoprilo; procedimiento de preparacion; composiciones farmaceuticas que la contienen; y su uso par el tratamiento de las enfermedades cardiovasculares, tales como hipertension arterial, insuficiencia cardiaca o enfermedad coronaria estable.
RU2004136583A (ru) Применение валсартана или его метаболита для ингибирования агрегации тромбоцитов
Chello et al. Intermittent warm blood cardioplegia induces the expression of heat shock protein-72 by ischemic myocardial preconditioning
CN207286247U (zh) 一种具有隐藏吊水杆结构的心内科护理床
CN100582120C (zh) 21-亚基地高辛衍生物及其制备方法
Migotto et al. Effects of vasopressin on hemodynamics in cardiogenic shock
CN102440812A (zh) 深部打结钳
Danica et al. Renal thromboembolism in tako-tsubo cardiomyopathy in spite of anticoagulation
HRP20130983T1 (hr) Derivati arilciklopropilacetamida, korisni kao aktivatori glukokinaze
Yuriivna et al. Ranolazine in treatment of stable angina in woman with atrial fibrillation and intermittent left bundle branch block-a case report
Wang et al. Structure-guided design of Cryptococcus neoformans protein farnesyltransferase inhibitors with antifungal activity
DK1718328T3 (da) Anvendelse af factor XIII til stimulering af gennemblödning i iskæmisk væv
RU2003123211A (ru) Способ родоразрешения пациенток с гестозом второй половины беременности
CN202146324U (zh) 一种改进的缝合针
Kocabay Ethinylestradiol/drospirenone Acute myocardial infarction: case report